Want to join the conversation?
$FSLR has raised the low end of its 2016 EPS guidance to $4.10. The company now expects EPS of $4.10-4.50 and net sales of $3.8-4Bil for 2016. Further, the company expects its operating expense to be in the range of $380-400MM and CapEx of $300-400MM for 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?